Skip to main content

Jonah Comstock

By Jonah Comstock | 11:26 am | May 06, 2015
Dexcom was one of the first companies to announce that it would have an Apple Watch app, and a recent FDA guideline made it clear that, as a secondary display device for a cleared CGM, the Apple Watch app wouldn't require its own clearance.
By Jonah Comstock | 10:54 am | May 06, 2015
Indianapolis-based pharma giant Eli Lilly is opening a new drug delivery and innovation center in Kendall Square in Cambridge, Massachusetts.
By Jonah Comstock | 10:02 am | May 06, 2015
Boston Children's Hospital's HealthMap A new editorial in Nature Biotech poses the idea of the "digital phenotype" as a catch-all term for the trail of relevant health data people leave behind in their interactions with the internet, social media, and technology, which has largely untapped potential for the early detection of various conditions.
By Jonah Comstock | 10:37 am | May 05, 2015
The Mersey Burns app is mentioned by name in the RCP guidelines.
By Jonah Comstock | 10:17 am | May 05, 2015
New York City-based digital healthcare service Sherpaa has raised an additional $2.
By Jonah Comstock | 06:47 am | May 05, 2015
Mountain View, California-based Amiigo, which makes an activity tracker that raised $580,000 on Indiegogo in 2013, has teamed up with online patient community platform Alliance Health to launch a new study looking at the combined effect of wearables and peer support on heart failure patients.
By Jonah Comstock | 11:16 am | May 04, 2015
Aliso Viego, California-based Sentrian, the remote patient monitoring company formerly known as Jointly Health, will work with Scripps Translational Science Institute to study its technology on 2,000 patients with COPD.
By Jonah Comstock | 11:12 am | May 04, 2015
Meridian Health subsidiary iMPak Health has teamed up with biomedical and healthcare technology group NetScientific to create a new digital health sales and marketing company called Triventis Health.
By Jonah Comstock | 10:56 am | May 04, 2015
Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app.